EcoDrugPlus

Carbonic Anhydrase 4-Like

Ensembl ID : ENSHCOG00000020468
Gene Symbol: LOC109514515
3 Cross references
196 Possible Orthologues:

Carbonic Anhydrase 4-Like

Ensembl ID : ENSHCOG00000010648
Gene Symbol: LOC109531136
3 Cross references
212 Possible Orthologues:

Carbonic Anhydrase 5a

Ensembl ID : ENSHCOG00000011998
Gene Symbol: CA5A
3 Cross references
231 Possible Orthologues:

Carbonic Anhydrase 6

Ensembl ID : ENSHCOG00000005888
Gene Symbol: CA6
3 Cross references
215 Possible Orthologues:

Carbonic Anhydrase 7

Ensembl ID : ENSHCOG00000003982
Gene Symbol: CA7
3 Cross references
221 Possible Orthologues:

Carbonic Anhydrase Iv C

Ensembl ID : ENSHCOG00000009198
Gene Symbol: CA4C
1 Cross references
79 Possible Orthologues:

Carbonic Anhydrase Xiv

Ensembl ID : ENSHCOG00000014032
Gene Symbol: CA14
1 Cross references
210 Possible Orthologues:

Casein Kinase 1 Epsilon

Ensembl ID : ENSHCOG00000006496
Gene Symbol: CSNK1E
3 Cross references
211 Possible Orthologues:

Casein Kinase I-Like

Ensembl ID : ENSHCOG00000011031
Gene Symbol: LOC109512392
3 Cross references
196 Possible Orthologues:

Caspase 9

Ensembl ID : ENSHCOG00000006536
Gene Symbol: CASP9
3 Cross references
202 Possible Orthologues:

Catechol-O-Methyltransferase B

Ensembl ID : ENSHCOG00000010157
Gene Symbol: COMTB
1 Cross references
215 Possible Orthologues:

Cathepsin C

Ensembl ID : ENSHCOG00000014852
Gene Symbol: CTSC
3 Cross references
237 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).